Sign in
4/A

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001209191-14-035626

President acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SCOTT TIMOTHY PHD President 2014-05-19 Option exercise +25,000 $0.95 $23,750 1,424,970 D
Derivatives
SCOTT TIMOTHY PHD President 2014-05-19 Option exercise · Stock Option (right to buy) −25,000 0 D
Loading xslF345X03/doc4a.xml…